Foundation Medicine will leverage its genomic profiling platform to detect multiple classes of genomic alterations.
Researchers report that approaches using precision medicine for cancer treatment, showed improved response and longer periods of remission.
A genetic mechanism could predict effectiveness of cure for particular cancers.
The increasing demand for personalized medicines is the key factor fueling the growth of the CDx market.
Mount Sinai researchers report on the clinical utility of a new personalized medicine program for cancer patients.
The MS causing genetic mutation should erase doubts that some forms of the neurological disease are inherited.
Clinicians need to understand the implications of genetic tests quickly and in clinical context.
Zephyr Health’s Insight as a Service platform focuses on actionable results for life sciences companies.